Genmab A/S (GMAB.CO)
| Previous close | 1,809.50 |
| Open | 1,778.00 |
| Bid | 1,761.00 x N/A |
| Ask | 1,762.00 x N/A |
| Day's range | 1,757.00 - 1,793.00 |
| 52-week range | 1,757.00 - 2,814.00 |
| Volume | |
| Avg. volume | 137,756 |
| Market cap | 112.388B |
| Beta (5Y monthly) | 0.81 |
| PE ratio (TTM) | 21.15 |
| EPS (TTM) | 83.06 |
| Earnings date | 01 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 2,668.05 |
GlobeNewswireCapital Increase in Genmab as a Result of Employee Warrant Exercise
Company Announcement COPENHAGEN, Denmark; June 18, 2024 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 6,986 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1: 424 shares at DKK 1,025.00,2,305 shares at DKK 1,032.00,1,058 shares at DKK 1,161.00,562 shares at DKK 1,210.00,287
- GlobeNewswire
Transactions in Connection with Share Buy-back Program
Company Announcement COPENHAGEN, Denmark; June 17, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5 billion worth of shares. The share buy-back program is expected to be completed no later than December 16, 2024. The following transactions were executed under the program from June 10, 2024, to June 14, 2024: Trading PlatformNo. of sharesAverage price (DKK)Total value (DKK)Accumulated through last announce
- GlobeNewswire
Grant of Restricted Stock Units and Warrants to Employees in Genmab
Company Announcement COPENHAGEN, Denmark; June 12, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that the Board decided to grant 15,711 restricted stock units and 16,052 warrants to employees of the Company and the Company's subsidiaries. Each restricted stock unit is awarded cost-free and provides the owner with a conditional right to receive one share in Genmab A/S of nominally DKK 1. The fair value of each restricted stock unit is equal to the closing market price on the date of grant of o
